Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.
Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, Lombaard J, Manongi R, Kapiga S, Kashuba A, Van Damme L; FEM-PrEP Study Group. Corneli AL, et al. Among authors: ahmed k. J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):324-31. doi: 10.1097/QAI.0000000000000158. J Acquir Immune Defic Syndr. 2014. PMID: 25157647 Free PMC article. Clinical Trial.
A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.
Corneli AL, McKenna K, Headley J, Ahmed K, Odhiambo J, Skhosana J, Wang M, Agot K; FEM-PrEP Study Group. Corneli AL, et al. Among authors: ahmed k. J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19152. doi: 10.7448/IAS.17.3.19152. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25224613 Free PMC article. Clinical Trial.
Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.
Friedland BA, Stoner M, Chau MM, Plagianos MG, Govender S, Morar N, Altini L, Skoler-Karpoff S, Ahmed K, Ramjee G, Monedi C, Maguire R, Lähteenmäki P. Friedland BA, et al. Among authors: ahmed k. AIDS Behav. 2016 Nov;20(11):2565-2577. doi: 10.1007/s10461-015-1123-x. AIDS Behav. 2016. PMID: 26204987 Free PMC article. Clinical Trial.
Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
Masson L, Barnabas S, Deese J, Lennard K, Dabee S, Gamieldien H, Jaumdally SZ, Williamson AL, Little F, Van Damme L, Ahmed K, Crucitti T, Abdellati S, Bekker LG, Gray G, Dietrich J, Jaspan H, Passmore JS. Masson L, et al. Among authors: ahmed k. Sex Transm Infect. 2019 Feb;95(1):5-12. doi: 10.1136/sextrans-2017-053506. Epub 2018 Jul 17. Sex Transm Infect. 2019. PMID: 30018088
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.
Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H. Delany-Moretlwe S, et al. Among authors: ahmed k. Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24. Lancet Infect Dis. 2018. PMID: 30507409 Clinical Trial.
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, Beksinska M, Donnell D, Baeten JM; ECHO Trial Consortium. Beesham I, et al. Among authors: ahmed k. J Int AIDS Soc. 2020 May;23(5):e25491. doi: 10.1002/jia2.25491. J Int AIDS Soc. 2020. PMID: 32396700 Free PMC article. Clinical Trial.
2,564 results